Healthcare & Biotech
-

Samsung Medison Buys Sonio for $92.7M to Boost AI Ultrasound
Samsung Medison acquires Sonio, a Paris-based AI ultrasound startup, for $92.7 million, improving medical imaging with FDA-cleared AI technology.
-

AlphaFold 3 Unlocks Secrets of Life’s Molecules
AlphaFold 3 by Google DeepMind revolutionizes biomolecular prediction, accelerating drug discovery, enabling wider research access, and sparking biomedical investments.
-

Deloitte Boosts Biosecurity with Gryphon Scientific Acquisition
Deloitte acquires Gryphon Scientific, enhancing biosecurity and AI safety. Integration boosts industry leadership and attracts investment opportunities for growth.
-

Yoneda Labs Boosts AI Drug Discovery with $4M Funding
Yoneda Labs raised $4M for AI drug discovery, funding expansion and a robotics lab to scale research capabilities. Potential market disruption expected.
-

Trovo Health Lands $15M for AI-Driven Healthcare
Trovo Health, based in NYC, secures $15M seed funding led by Oak HC/FT, aiming to advance AI-enhanced healthcare services.
-

Xaira Therapeutics Debuts with $1B, Eyes AI Revolution in Medicine
Xaira Therapeutics, based in San Francisco, has launched with over $1 billion in funding for AI-driven drug development.
-

Alaffia Health’s $10M Boost to Revolutionize AI in Health Claims
Alaffia Health, a NYC-based AI firm, secures $10M funding from leading investors to enhance generative AI applications for health plan claim operations.
-

AI-Driven Gene Editing Promises Faster Disease Control
Profluent’s AI gene editor, OpenCRISPR-1, accelerates disease treatment and research, with potential for personalized healthcare and investment opportunities.
-

Auxa Health Secures $5.2M for AI-Driven Healthcare Navigation
Auxa Health secures $5.2M funding from Zeal Capital Partners, AlleyCorp, K50 Ventures, Laconia Capital Group, and Chaac Ventures for healthcare innovation.
-

Somite Secures $5.3M to Revolutionize Stem Cell Therapies with AI
Somite secures $5.3M pre-seed funding led by TechAviv, advancing AlphaStem AI for stem cell biology, potentially accelerating disease therapies.
